These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 18625113)

  • 1. Beta-cell failure in type 2 diabetes mellitus.
    Lencioni C; Lupi R; Del Prato S
    Curr Diab Rep; 2008 Jun; 8(3):179-84. PubMed ID: 18625113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-cell function and mass in type 2 diabetes.
    Larsen MO
    Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and characterization of a novel rat model of type 2 diabetes mellitus: the UC Davis type 2 diabetes mellitus UCD-T2DM rat.
    Cummings BP; Digitale EK; Stanhope KL; Graham JL; Baskin DG; Reed BJ; Sweet IR; Griffen SC; Havel PJ
    Am J Physiol Regul Integr Comp Physiol; 2008 Dec; 295(6):R1782-93. PubMed ID: 18832086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-Cell Mass in Obesity and Type 2 Diabetes, and Its Relation to Pancreas Fat: A Mini-Review.
    Inaishi J; Saisho Y
    Nutrients; 2020 Dec; 12(12):. PubMed ID: 33339276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic Fat is not significantly correlated with β-cell Dysfunction in Patients with new-onset Type 2 Diabetes Mellitus using quantitative Computed Tomography.
    Li YX; Sang YQ; Sun Y; Liu XK; Geng HF; Zha M; Wang B; Teng F; Sun HJ; Wang Y; Qiu QQ; Zang X; Wang Y; Wu TT; Jones PM; Liang J; Xu W
    Int J Med Sci; 2020; 17(12):1673-1682. PubMed ID: 32714070
    [No Abstract]   [Full Text] [Related]  

  • 6. beta-cell failure in diabetes and preservation by clinical treatment.
    Wajchenberg BL
    Endocr Rev; 2007 Apr; 28(2):187-218. PubMed ID: 17353295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection of pancreatic beta-cells: is it feasible?
    Bonora E
    Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):74-83. PubMed ID: 18096375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights on the current status and advancement of diabetes mellitus type 2 and to avert complications: An overview.
    Chung IM; Rajakumar G; Subramanian U; Venkidasamy B; Khanna VG; Thiruvengadam M
    Biotechnol Appl Biochem; 2020 Nov; 67(6):920-928. PubMed ID: 31736194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of FOXO1 in β-cell failure and type 2 diabetes mellitus.
    Kitamura T
    Nat Rev Endocrinol; 2013 Oct; 9(10):615-23. PubMed ID: 23959366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of beta-cell dysfunction, ectopic fat accumulation and insulin resistance in the pathogenesis of type 2 diabetes mellitus.
    Gastaldelli A
    Diabetes Res Clin Pract; 2011 Aug; 93 Suppl 1():S60-5. PubMed ID: 21864753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of inflammatory mechanisms in pathogenesis of type 2 diabetes mellitus.
    Akash MS; Rehman K; Chen S
    J Cell Biochem; 2013 Mar; 114(3):525-31. PubMed ID: 22991242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impairment of glucose-stimulated insulin secretion in pancreatic β-cells caused by prolonged glucotoxicity and lipotoxicity is associated with elevated adaptive antioxidant response.
    Fu J; Cui Q; Yang B; Hou Y; Wang H; Xu Y; Wang D; Zhang Q; Pi J
    Food Chem Toxicol; 2017 Feb; 100():161-167. PubMed ID: 28027979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interplay of insulin resistance and beta-cell dysfunction involves the development of type 2 diabetes in Chinese obeses.
    Hong J; Gu WQ; Zhang YF; Yang YS; Shen CF; Xu M; Li XY; Wang WQ; Ning G
    Endocrine; 2007 Apr; 31(2):93-9. PubMed ID: 17873317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dracorhodin perchlorate protects pancreatic β-cells against glucotoxicity- or lipotoxicity-induced dysfunction and apoptosis in vitro and in vivo.
    Liu L; Liang C; Mei P; Zhu H; Hou M; Yu C; Song Z; Bao Y; Huang Y; Yi J; Wang S; Wu Y; Zheng L; Sun Y; Wang G; Huo M; Yang S; Sun L; Li Y
    FEBS J; 2019 Sep; 286(18):3718-3736. PubMed ID: 31349381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deficiency of Urokinase Plasminogen Activator May Impair β Cells Regeneration and Insulin Secretion in Type 2 Diabetes Mellitus.
    Wu CZ; Ou SH; Chang LC; Lin YF; Pei D; Chen JS
    Molecules; 2019 Nov; 24(23):. PubMed ID: 31756973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diet-induced β-cell insulin resistance results in reversible loss of functional β-cell mass.
    Paschen M; Moede T; Valladolid-Acebes I; Leibiger B; Moruzzi N; Jacob S; García-Prieto CF; Brismar K; Leibiger IB; Berggren PO
    FASEB J; 2019 Jan; 33(1):204-218. PubMed ID: 29957055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetic Retinopathy in Newly Diagnosed Subjects With Type 2 Diabetes Mellitus: Contribution of β-Cell Function.
    Roy Chowdhury S; Thomas RL; Dunseath GJ; Peter R; Rees DA; North RV; Luzio SD; Owens DR
    J Clin Endocrinol Metab; 2016 Feb; 101(2):572-80. PubMed ID: 26652932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes mellitus and the β cell: the last ten years.
    Ashcroft FM; Rorsman P
    Cell; 2012 Mar; 148(6):1160-71. PubMed ID: 22424227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type 2 diabetes mellitus.
    DeFronzo RA; Ferrannini E; Groop L; Henry RR; Herman WH; Holst JJ; Hu FB; Kahn CR; Raz I; Shulman GI; Simonson DC; Testa MA; Weiss R
    Nat Rev Dis Primers; 2015 Jul; 1():15019. PubMed ID: 27189025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Balancing needs and means: the dilemma of the beta-cell in the modern world.
    Leibowitz G; Kaiser N; Cerasi E
    Diabetes Obes Metab; 2009 Nov; 11 Suppl 4():1-9. PubMed ID: 19817783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.